Company

Share

分配年度 分配预案的股本基数(股) 分配方案(每10股) 现金分红总额(元)(含税) 股权登记日 除权/除息日 分红派息日 送红股(... 【More>>】

优得清角膜

分配年度 分配预案的股本基数(股) 分配方案(每10股) 现金分红总额(元)(含税) 股权登记日 除权/除息日 分红派息日 送红股(股) 转增股(股) ... 【More>>】

左6

Grandhope Biotech successfully listed on Shenzhen GEM

July 6, 2011, Grandhope Biotech successfully listed on Shenzhen GEM (growth enterprise market), with the stock code 300238. The share circulation of this time is 1,530 million, with the price of 18.20 RMB per share and the P/E ratio of 38.16. The money raised from the shares is mainly used for the construction of the“National Engineering Laborator... 【More>>】

Postdoctoral Programme

Recently, the ministry of human resources and social security and the committee of national postdoctoral management have released the notice that 489 enterprises were authorized to establish postdoctoral research station. Grandhope Biotech was successfully listed. The application of the postdoctoral research station needs to pass a strict... 【More>>】

Deloitte Technology Fast 50 China and 500 Asia Pacific 2010

On Dec. 2 2010, the award ceremony of "Deloitte Technology Fast 50 China and 500 Asia Pacific" is held in Hong Kong. In this selection, 147 enterprises of mainland China have been on list, which become the most of the Asia Pacific region. With the rapid growth of the last three years, Grandhope Biotech has again been on the list since th... 【More>>】

Sitemap

关于皇家金堡 企业概述 企业学问 生产基地 管理团队 发展战略 领导关怀 企业荣誉 企业大事记 科技研发 皇家金堡技术 皇家金堡材料 资质证书 产品先容 产品特点 上市产品 在研产品 再生医学工程研究院 国家工程实验室 资讯资讯 最新热点 企业动态 媒体报道 营销网络 国内网络 国际网络 投资者关系 人才招聘 用人之道 薪酬福利 职业发展 招聘流程 招聘信息 联系... 【More>>】

2014年度股东大会决议公告(en)

Sitemap

关于皇家金堡 企业概述 企业学问 发展历程 企业荣誉 核心团队 领导关怀 分子企业 联系大家 资讯中心 企业动态 行业资讯 视频中心 产业布局 再生材料领域 细胞领域 干细胞领域 孵化创投 服务支撑 营销网络 售后服务 国家工程实验室 国家工程实验室 组织架构 研发团队 研发项目 投资者关系 股市行情 互动平台 定期报告 临时公告 法人治理 资讯资讯 投资者关系管理 用人之道 人才培育 招贤纳士 冠... 【More>>】

2015年3月11日投资者关系活动报告(en)

《企业章程》(2015年2月)(en)

干细胞与转化医学重点专项实施方案征求意见(en)

干细胞与转化医学重点专项实施方案征求意见 (en) 链接地址:http://www.most.gov.cn/tztg/201502/t20150226_118286.htm 日期:2015年02月26日 来源:科技部 根据国务院《关于深化中央财政科技计划(专项、基金等)管理改革的方案》总体要求,科技部将会同有关部门,启动国家重点研发计划“干细胞与转化医学”重点专项试点工作... 【More>>】

2014年年度报告摘要(en)

医疗器械分类规则(修订草案) (征求意见稿)(en)

境内医疗器械注册质量管理体系核查操作规范(en)

《医疗器械标准管理办法》(en)

大动脉覆膜支架系统的临床试验引导原则(en)

《医疗器械经营监督管理办法》(局令第8号)(en)

《医疗器械生产监督管理办法》(局令第7号)(en)

2011 Forbes China Up & Comers

Recently, the Forbes China has released the list of 2011 Forbes China Up and Comers. 200 enterprises were on the list. With the rapid and stable development, Grandhope Biotech has been successfully selected again, ranking 57th this year. It’s the seventh time that Forbes has such a comprehensive and independent investigation during Chinese small and medium-sized enterprises, whic... 【More>>】

2011 Forbes China Up & Comers

Recently, the Forbes China has released the list of 2011 Forbes China Up and Comers. 200 enterprises were on the list. With the rapid and stable development, Grandhope Biotech has been successfully selected again, ranking 57th this year. It’s the seventh time that Forbes has such a comprehensive and independent investigation during Chinese small and medium-sized enterprises, whic... 【More>>】

NormalGEN ? dura repair patch

Biomaterials Field

Technologies We have established a series of proprietary technologies, turning animal tissues into regenerative medical materials, and overcoming traditional methods of having permanent foreign materials inside the body. 1.Tissue Fixation: using innovative epoxy crosslinking technique, we are able to fix the tissue at a pre-determined bio-stability. The degradation rate is synchronized w... 【More>>】

Biomaterials Field

Materials Key advantages of Guanhao Materials: 1.Similar composition and structure to that of the replaced tissues. 2.Superior biocompatibility to host tissues. 3.Excellent mechanical properties such as compliance and strength. 4.Synchronized degradation rates with host tissue regeneration. 5.Promotes host tissue and organ regeneration. The regenerative medical materia... 【More>>】

Guanhao

Immune cell bank Everyone has its own immune cells to protect the health. The mechanism of immune cell therapy is to use people’s own immune cells to fight against diseases, namely using cells expanded in vitro to enhance the ability of people to fight against pathogens. A key factor of immune cell therapy is the good T cells. When people are getting old, immune cells will degenerate. A... 【More>>】

BEIHAO STEM CELL AND REGENERATIVE MEDICINE RESEARCH INSTITUTE

Stem cells are a group of multipotent cells with the self-renewal ability. In certain conditions, they can differentiate into many functional cells, which have the potential to regenerate tissues and organs and even the human body. Stem cell technologies, or regenerative medicine technologies, are the most prosperous and fast developing in the biotechnology field. Stem cell and regenerati... 【More>>】

Adhering to the market-oriented business philosophy,Guanhao Biotech has established a well-trained sales team and distribution network covering the whole China. In 2008, our Shanghai branch has been set up as a marketing center for the company, responsible for sales of Guanhao products in both domestic and overseas market. Soon afterwards, more branch companies have been set up in B... 【More>>】

Constructing 【More>>】

2008-09 Chairman Xi Jinping of China visited

2008年12月,国家主席习大大听取徐斌总经理汇报 【More>>】

zhang

1999

1999 In Oct. 1999 Guanhao Biotech founded in Guangzhou, China 【More>>】

Corporate Culture We know, An excellent enterprise, is to create a can make all the staff in unision core values and sense of mission, a can promote staff and progressive work environment, one can ensure that enterprises operating performance and constantly improve the system arrangement to actively promote the organizational change and deve... 【More>>】

About Us

About Us Guanhao Biotech is a company focusing on regenerative medicine industry, expanding its business to life science fields. The company builds bridges to globe-wide high-end technological resources and achievements and keeps investing in the area of biomaterials, stem cells, pharmaceutical industry and advanced medical technologies, resulting in a form of "3+... 【More>>】

Grandhope Biotech successfully listed on Shenzhen GEM

July 6, 2011, Grandhope Biotech successfully listed on Shenzhen GEM (growth enterprise market), with the stock code 300238. The share circulation of this time is 1,530 million, with the price of 18.20 RMB per share and the P/E ratio of 38.16. The money raised from the shares is mainly used for the construction of the“National Engineering Laboratory for Regenerative Implantable Me... 【More>>】